Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes
- 15 April 2005
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 95 (8), 976-978
- https://doi.org/10.1016/j.amjcard.2004.12.039
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Risk of acute first myocardial infarction and use of nicotine patches in a general populationJournal of the American College of Cardiology, 2001
- Regular review: Effectiveness of interventions to help people stop smoking: findings from the Cochrane LibraryBMJ, 2000
- 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and RecommendationsCirculation, 1999
- A Meta-Analysis to Assess the Incidence of Adverse Effects Associated with the Transdermal Nicotine PatchDrug Safety, 1998
- Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.Circulation, 1994
- Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-upJournal of the American College of Cardiology, 1992
- How soon after quitting smoking does risk of heart attack decline?Journal of Clinical Epidemiology, 1991
- Antismoking productsThe Medical Journal of Australia, 1990
- Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgeryJournal of the American College of Cardiology, 1988
- Cigarette Smoking and the Treatment of Angina with Propranolol, Atenolol, and NifedipineNew England Journal of Medicine, 1984